A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer

Clinical trial NCT02314117 · COMPLETED

Trial details

NCT number: NCT02314117
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2015-01-20
Primary completion: 2017-01-17
Enrollment: 645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.